FDA postpones adcomm for Pfizer's Covid-19 vaccine for the youngest age group
The FDA on Friday afternoon said it’s no longer moving forward with its plan to authorize two doses (while waiting for data on a third …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
